Laura Sepp-Lorenzino – Biography
Last update: 16 days agoExecutive profile
Laura was Vice President, Head Nucleic Acid Therapies, External Innovation at Vertex Pharmaceuticals, and Vice President, Entrepreneur in Residence at Alnylam Pharmaceuticals. Laura Sepp-Lorenzino joined Taysha Gene Therapies in 2025.
Laura Sepp-Lorenzino is currentlyDirector at Lexeo Therapeutics - View - Lexeo Therapeutics org chart
Director at Taysha Gene Therapies - View - Taysha Gene Therapies org chart
Independent Director at AskBio - View - AskBio org chart
Create your alert
to follow the career of Laura Sepp-Lorenzino.
Education
Laura Sepp-Lorenzino has a PhD in Biochemistry from New York University.
They have also studied at New York University :
Find more alumni from New York University
More about Laura Sepp-Lorenzino
Selected links
Do you need to know more about Laura Sepp-Lorenzino? More results.
Participate
Social media
- Laura Sepp-Lorenzino on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Laura Sepp-Lorenzino
The colleagues of Laura Sepp-Lorenzino
Company Colleagues
- At Lexeo Therapeutics, Laura Sepp-Lorenzino has 25 colleagues including Nolan Townsend (CEO & Director), Mette Kirstine Agger (Director)…
- At Taysha Gene Therapies, Laura Sepp-Lorenzino has 13 colleagues including Sean Nolan (CEO & Chairman), Alison Long (Director)…
- At AskBio, Laura Sepp-Lorenzino has 29 colleagues including Gustavo Pesquin (CEO), Olivier Mauroy-Bressier (Director)…
Industry Colleagues
- In the Biotechnology industry, Laura Sepp-Lorenzino has 35,765 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Laura Sepp-Lorenzino.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Laura Sepp-Lorenzino.
